Met Life Investment Management, LLC Codiak Bio Sciences, Inc. Call Options Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CDAK
# of Institutions
1Shares Held
238KCall Options Held
0Put Options Held
0About Codiak BioSciences, Inc.
- Ticker CDAK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,995,200
- Market Cap $360K
- Description
- Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...